Free Trial

Berenberg Bank Reiterates "Buy" Rating for CLS (LON:CLI)

CLS logo with Real Estate background

CLS (LON:CLI - Get Free Report)'s stock had its "buy" rating restated by equities researchers at Berenberg Bank in a research report issued on Tuesday, Marketbeat Ratings reports. They currently have a GBX 114 ($1.47) price objective on the stock. Berenberg Bank's target price points to a potential upside of 80.95% from the company's previous close.

CLS Trading Down 1.9 %

LON:CLI traded down GBX 1.20 ($0.02) on Tuesday, reaching GBX 63 ($0.81). The stock had a trading volume of 1,698,544 shares, compared to its average volume of 1,144,992. CLS has a 12-month low of GBX 62.50 ($0.81) and a 12-month high of GBX 101.40 ($1.31). The company has a market cap of £251.05 million, a price-to-earnings ratio of -1.21 and a beta of 1.01. The firm's fifty day moving average is GBX 71.24 and its two-hundred day moving average is GBX 81.20. The company has a debt-to-equity ratio of 123.30, a current ratio of 0.73 and a quick ratio of 0.59.

CLS (LON:CLI - Get Free Report) last announced its earnings results on Tuesday, April 1st. The company reported GBX (23.60) (($0.30)) earnings per share (EPS) for the quarter. CLS had a negative return on equity of 23.42% and a negative net margin of 134.11%. Equities analysts expect that CLS will post 10.0104167 EPS for the current fiscal year.

CLS Company Profile

(Get Free Report)

We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants' businesses to grow.

Recommended Stories

Should You Invest $1,000 in CLS Right Now?

Before you consider CLS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CLS wasn't on the list.

While CLS currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines